webvic-b

Poultry

The company expects to begin shipping in volume in the third quarter of 2024. (Image source: Adobe Stock)

Following rigorous development and testing, leader in molecular sensing and diagnostics, Alveo Technologies, Inc (Alveo) recently announced that the Flockscreen LAMP Avian Influenza Molecular Test was capable of accurately detecting the presence of virus in both cloacal and oropharyngeal samples from poultry with comparable limit of detection, sensitivity and specificity

The HPAI panzootic virus has spread to not only cattle, but at least 47 other mammalian species, resulting in the destruction of more than half a billion poultry worldwide. One among the many significant drawbacks that make current agricultural tests unsuitable for these HPAI use cases, includes the lengthy processing time required to obtain a result from polymerase chain reaction (PCR). Moreover, vaccinating birds can cause their serology tests to turn positive despite not being infected. In addition, lateral flow, also known as antigen or instant tests, lacks sensitivity and produces a significant percentage of false negative results.

However, Alveo's portable and rugged molecular diagnostic platform has been designed to provide accurate, rapid test results at the point of need. It functions as a core component of a notifiable disease electronic management ecosystem that the company and its strategic partners have developed to support producers, as well as governmental bodies who are looking to expand the surveillance of important zoonotic pathogens. 

Two multiplexed panels enable the on-site broad detection of Avian Influenza Type A virus (targeting matrix gene) in poultry with differentiation of H5, H7 and H9 subtypes using oropharyngeal or cloacal samples. Both panels contain seven assays, six of which are identical between cartridges. This configuration ensures the greatest coverage of the most clinically relevant global AI strains from the past 5-10 years, through to the current strains. The platform's rugged design enables it to function in the field under extreme conditions, including very hot and near freezing temperatures, following a drop of one metre, and when subjected to movement and vibration, which are common challenges encountered in field settings. 

During their evaluation of over 100 candidate primer sets and assay conditions, Alveo and their development partners performed more than 20,000 reactions on over 4000 assay cartridges using both contrived and clinical samples.

"Our platform makes it simple to test for HPAI in poultry and we will be the first diagnostic of its kind that can test both cloacal and oropharyngeal samples," said CEO of Alveo, Shaun Holt. "Our rugged design enables healthcare providers, veterinarians, growers, and public health officials to obtain rapid results at point of need so they can take immediate action."

The product will be validated and verified by relevant regulatory bodies prior to shipment. Shipping of the product, which is currently available for pre-sale in Europe and the Middle East, is set to begin in the third quarter of 2024.

Solar power is seen as a game-changer in reducing operational expenses and bolstering the competitiveness of the agricultural industry. (Image source: LONGi)

A poultry farm in the Philippines has embraced Hi-MO X6, which was installed across the rooftops of the farm, pioneering a low-carbon, and sustainable agricultural paradigm

Under the mission of 'To make the best of solar energy to build a green world', the world's leading solar technology company, LONGi is at the forefront of bringing photovoltaic technology to cultivate an agriculture sector that thrives in harmony with nature. 

Equipped with HPBC cell technology and having an estimated annual generation of 300,000 kWh, Hi-MO X6 supplies the farm's energy needs and anticipates a net CO₂ emission reduction of 4439 tonnes over its lifetime – a figure equivalent to the CO₂ absorption of 14,796 trees over 30 years.

Boasting a 2.27% increase in light absorption, Hi-MO X6 significantly enhances power output, with empirical tests revealing that Hi-MO X6 operates for 5.8 hours per day, surpassing the average four-hour generation time of mainstream products. Annually, this amounts to an additional 1182.6 generation hours and yields for users.

Being the first to offer full rear-side soldering, Hi-MO X6 considerably improves anti-crack capabilities and exhibits exceptional performance in severe weather resilience tests. Moreover, these panels also passed the TUV SUD ammonia corrosion test, ensuring stable and efficient power and securing daily operations at the poultry farm.

For more information, visit: www.longi.com  

The implementation of this system across its poultry farms has greatly helped in raising Thai poultry standards. (Image source: Adobe Stock)

As part of its innovative strategy to safeguard poultry production, Thailand-based Charoen Pokphand Foods (CP Foods) recently adopted the compartment scheme, thereby assuring disease-free poultry operations

The compartment system involves implementing strict biosafety and disease surviellance standards to maintain a closed-farm environment. To minimise the risk of diseases like Avian Influenza (AI) and Newcastle Disease (ND), veterinary specialists carry out regular pathogen tests for bird flu, Salmonella and the Newcastle virus. Through this initiative, the company highlights the importance of food safety both for raw and cooked products.

The disease control strategy of the compartment system is based on four pillars including, rigorous biosecurity measures, proactive bird flu surveillance, specific disease control within farms and surrounding areas, and a traceability system to monitor the food chain. By employing advanced closed house facilities comprising an evaporative cooling system, CP Foods leverages artificial intelligence (AI) and IoT for week-long animal health monitoring, thus significantly reducing disease risk through minimal human contact.

The implementation of this system across its poultry farms has greatly helped in raising Thai poultry standards through knowledge transfer, contract farming, and standardised disease prevention measures. Besides improving the overall resilence of the Thai poultry sector and economy, the implementation of the compartment system also enhances farm yields and income stability for farmers.

For more information, visit: https://www.cpfworldwide.com/ 

Global trends in egg production have continued to evolve toward more humane and sustainable practices. (Image source: Adobe Stock)

A new survey has revealed that more than 80% of Malaysians favour humane farming, urging Chinese and Malaysian egg producers to hold a collaborative education and sharing session on 8 May, to discuss the growing market opportunity in cage-free egg production

Hosted by the Beijing Egg Industry Association, consultancy Lever China, and international NGO Lever Foundation, the event entitled, 'Sino-Malaysia Cage-Free Egg Symposium: Unlocking Success Together,' aims to equip Malaysian egg producers with insights from leading Chinese egg producers in China who have expanded to include cage-free production in response to growing corporate and consumer demand. 

The event comes as a new survey conducted by GMO Research finds that an overwhelming 83% agree that food companies should source their eggs from a supply chain that adheres to humane standards of animal treatment. Additionally, nearly 60% of Malaysian consumers said they were more inclined to patronise a food brand that sourced only cage-free eggs and more than 60% were also willing to pay more for cage-free eggs if they were slightly more expensive than traditional caged eggs.

Based on current corporate commitments in Malaysia, Lever Foundation predicts that the demand for cage-free eggs will increase by 395 million eggs per year within the next several years.Global trends in egg production have continued to evolve toward more humane and sustainable practices, as numerous studies by the European Food Safety Authority and others have consistently found cage-free production to have far lower rates of salmonella contamination, making them healthier and safer for consumers. 

"In addition to the increasing demand from consumers for cage-free eggs, a growing number of food companies have committed to only source eggs from cage-free supply chains, which will require an increase in cage-free production in the Malaysian market," said Vilosha Sivaraman, Sustainability Programme manager at Lever Foundation, which supports food companies in Malaysia transition toward cage-free eggs.

For more information about the event, visit: https://form.evenesis.com/cage-free2024 

The joint venture aims to develop and expand gut health solutions products including probiotics for farm animals in China. (Image source: Vland Biotech)

Evonik Vland Biotech, a joint venture co-built by Evonik China Co Ltd and Shandong Vland Biotech Co Ltd. officially commenced operation on 14 March in Qingdao, China 

Headquartered in Vland Biotech Innovation Park in Qingdao, the joint venture aims to develop and expand gut health solutions products including probiotics for China's farm animals. Head of Evonik's life science division Nutrition & Care, the Animal Nutrition business line, Johann-Caspar Gammelin highlighted that their cooperation with Vland was a crucial step in realising their commitment to providing biosolutions including probiotics for animal gut health for the feed industry. 

The agreement will allow Evonik to distribute the joint venture’s portfolio outside of the Greater China region, while also allowing the company to expand its gut health solutions by adding broader formulation elements to its global product portfolio. 

"Vland and Evonik have been expanding and deepening our cooperation areas in the past decade," said chairman and president of Vland Group, Chen Gang. The joint venture will make full use of and give full play to each other’s strengths, and deliver efficient products and solutions in animal gut health for users both in China and abroad."

General manager of Evonik Vland Biotech (Shandong) Co Ltd., Dr Wang Xu agreed that the joint venture would greatly benefit from the strong innovation capabilities, applied technology expertise and excellent reputation of the two parent companies, thereby delivering innovative products and solutions to the market and creating more value for their customers. 

For more information, visit: https://corporate.evonik.cn/en and http://www.vlandbiochem.com/ 

More Articles …